OSTO:PROB (Sweden)
Business Description
Probi AB
Ideongatan 1 A, Lund, SWE, SE-223 70
Compare
Compare
Traded in other countries / regions
PROB.Sweden
•
0GZB.UK
•
PBBIF.USA
Description
Probi AB is engaged in probiotic research and development, manufacturing and sales of effective and well-documented probiotics. The company's research relates to living microorganisms with scientifically proven health benefits. The main fields of research are gut health, immune system and nutrient absorption, iron absorption, bone health and stress and recovery. Its segments are Consumer Healthcare (CHC) and Functional Food (FF). The company operates in United States, Americas, excluding the US , Sweden, EMEA, excluding Sweden, and APAC.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.42 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | 0.43 | |||||
| Interest Coverage | 48.22 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 12.07 | |||||
| Beneish M-Score | -1.88 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.9 | |||||
| 3-Year EBITDA Growth Rate | 5 | |||||
| 3-Year EPS without NRI Growth Rate | 3 | |||||
| 3-Year FCF Growth Rate | -0.6 | |||||
| 3-Year Book Growth Rate | 7.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.29 | |||||
| 9-Day RSI | 39.19 | |||||
| 14-Day RSI | 42.86 | |||||
| 6-1 Month Momentum % | -28.01 | |||||
| 12-1 Month Momentum % | -45.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | |||||
| Quick Ratio | 5.17 | |||||
| Cash Ratio | 3.39 | |||||
| Days Inventory | 101.52 | |||||
| Days Sales Outstanding | 59.26 | |||||
| Days Payable | 35.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.53 | |||||
| Dividend Payout Ratio | 0.19 | |||||
| Forward Dividend Yield % | 0.53 | |||||
| 5-Year Yield-on-Cost % | 0.53 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.48 | |||||
| Operating Margin % | 15.46 | |||||
| Net Margin % | 11.96 | |||||
| ROE % | 6.2 | |||||
| ROA % | 5.55 | |||||
| ROIC % | 7.05 | |||||
| ROC (Joel Greenblatt) % | 32.02 | |||||
| ROCE % | 7.62 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 35.31 | |||||
| PE Ratio without NRI | 35.82 | |||||
| Shiller PE Ratio | 37.83 | |||||
| Price-to-Owner-Earnings | 26 | |||||
| PEG Ratio | 21.07 | |||||
| PS Ratio | 4.22 | |||||
| PB Ratio | 2.01 | |||||
| Price-to-Tangible-Book | 4.36 | |||||
| Price-to-Free-Cash-Flow | 36.18 | |||||
| Price-to-Operating-Cash-Flow | 21.03 | |||||
| EV-to-EBIT | 25.34 | |||||
| EV-to-EBITDA | 14.31 | |||||
| EV-to-Revenue | 3.94 | |||||
| EV-to-FCF | 34.26 | |||||
| Price-to-Projected-FCF | 1.28 | |||||
| Price-to-Median-PS-Value | 0.7 | |||||
| Price-to-Graham-Number | 2.62 | |||||
| Price-to-Net-Current-Asset-Value | 7.8 | |||||
| Price-to-Net-Cash | 26.46 | |||||
| Earnings Yield (Greenblatt) % | 3.95 | |||||
| Forward Rate of Return (Yacktman) % | 8.16 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 658.133 | ||
| EPS (TTM) (kr) | 6.91 | ||
| Beta | 1.27 | ||
| Volatility % | 42.52 | ||
| 14-Day RSI | 42.86 | ||
| 14-Day ATR (kr) | 15.174639 | ||
| 20-Day SMA (kr) | 256.475 | ||
| 12-1 Month Momentum % | -45.67 | ||
| 52-Week Range (kr) | 205.5 - 519 | ||
| Shares Outstanding (Mil) | 11.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Probi AB Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||